Bleakley Financial Group »

Unicycive Therapeutics shares owned by Bleakley Financial Group

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Bleakley Financial Group from 13F filings

Historical chart of Bleakley Financial Group investment in Unicycive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Bleakley Financial Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $33k 80k 0.41

More positions owned by Bleakley Financial Group

Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
Sprott Physical Gold & Silve Tr Unit (CEF)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Value Etf (VTV)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
NVIDIA Corporation (NVDA)
Sprott Physical Gold Tr Unit (PHYS)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Vanguard Malvern Fds Strm Infproidx (VTIP)

View all positions for Bleakley Financial Group

Top funds holding Unicycive Therapeutics

Octagon Capital Advisors
Dr. Jeffrey R. Jay, M.D.
Logos Global Management
Nantahala Capital Management
Alyeska Investment Group
Vanguard Group
LPL Financial
Geode Capital Management
Goldman Sachs Group
Bleakley Financial Group
BlackRock
BlackRock
State Street Corporation
Jane Street
Northern Trust

View all funds holding Unicycive Therapeutics